169 related articles for article (PubMed ID: 37147361)
21. METTL13 inhibits progression of clear cell renal cell carcinoma with repression on PI3K/AKT/mTOR/HIF-1α pathway and c-Myc expression.
Liu Z; Sun T; Piao C; Zhang Z; Kong C
J Transl Med; 2021 May; 19(1):209. PubMed ID: 33985542
[TBL] [Abstract][Full Text] [Related]
22. Site specificity of four pyruvate dehydrogenase kinase isoenzymes toward the three phosphorylation sites of human pyruvate dehydrogenase.
Korotchkina LG; Patel MS
J Biol Chem; 2001 Oct; 276(40):37223-9. PubMed ID: 11486000
[TBL] [Abstract][Full Text] [Related]
23. Metabolic Connection of Inflammatory Pain: Pivotal Role of a Pyruvate Dehydrogenase Kinase-Pyruvate Dehydrogenase-Lactic Acid Axis.
Jha MK; Song GJ; Lee MG; Jeoung NH; Go Y; Harris RA; Park DH; Kook H; Lee IK; Suk K
J Neurosci; 2015 Oct; 35(42):14353-69. PubMed ID: 26490872
[TBL] [Abstract][Full Text] [Related]
24. Prognostic value of JAK3 promoter methylation and mRNA expression in clear cell renal cell carcinoma.
Long Q; Huang C; Huang J; Meng Q; Cheng Y; Li Y; He L; Chen M; Zhang C; Wang X; Zhu W; Peng J; Shi D; Zheng F; Dong P; Deng W
J Adv Res; 2022 Sep; 40():153-166. PubMed ID: 36100323
[TBL] [Abstract][Full Text] [Related]
25. Interaction between the individual isoenzymes of pyruvate dehydrogenase kinase and the inner lipoyl-bearing domain of transacetylase component of pyruvate dehydrogenase complex.
Tuganova A; Boulatnikov I; Popov KM
Biochem J; 2002 Aug; 366(Pt 1):129-36. PubMed ID: 11978179
[TBL] [Abstract][Full Text] [Related]
26. Three members of the human pyruvate dehydrogenase kinase gene family are direct targets of the peroxisome proliferator-activated receptor beta/delta.
Degenhardt T; Saramäki A; Malinen M; Rieck M; Väisänen S; Huotari A; Herzig KH; Müller R; Carlberg C
J Mol Biol; 2007 Sep; 372(2):341-55. PubMed ID: 17669420
[TBL] [Abstract][Full Text] [Related]
27. Expression of CX3CR1 associates with cellular migration, metastasis, and prognosis in human clear cell renal cell carcinoma.
Yao X; Qi L; Chen X; Du J; Zhang Z; Liu S
Urol Oncol; 2014 Feb; 32(2):162-70. PubMed ID: 23570708
[TBL] [Abstract][Full Text] [Related]
28. Increased expression of tribbles homolog 3 predicts poor prognosis and correlates with tumor immunity in clear cell renal cell carcinoma: a bioinformatics study.
Wu XQ; Tian X; Xu FJ; Wang Y; Xu WH; Su JQ; Qu YY; Zhao JY; Zhang HL; Ye DW
Bioengineered; 2022 May; 13(5):14000-14012. PubMed ID: 35726370
[TBL] [Abstract][Full Text] [Related]
29. Significance of PI3K signalling pathway in clear cell renal cell carcinoma in relation to VHL and HIF status.
Tumkur Sitaram R; Landström M; Roos G; Ljungberg B
J Clin Pathol; 2021 Apr; 74(4):216-222. PubMed ID: 32467322
[TBL] [Abstract][Full Text] [Related]
30. Interleukin 20 receptor subunit beta (IL20RB) predicts poor prognosis and regulates immune cell infiltration in clear cell renal cell carcinoma.
Zhang H; Liu Y; Wang B; Wang C
BMC Genom Data; 2022 Jul; 23(1):58. PubMed ID: 35883015
[TBL] [Abstract][Full Text] [Related]
31. FABP5 regulates the proliferation of clear cell renal cell carcinoma cells via the PI3K/AKT signaling pathway.
Lv Q; Wang G; Zhang Y; Han X; Li H; Le W; Zhang M; Ma C; Wang P; Ding Q
Int J Oncol; 2019 Apr; 54(4):1221-1232. PubMed ID: 30968158
[TBL] [Abstract][Full Text] [Related]
32. Immune inactivation by CD47 expression predicts clinical outcomes and therapeutic responses in clear cell renal cell carcinoma patients.
Jiang W; Zeng H; Liu Z; Jin K; Hu B; Chang Y; Liu L; Zhu Y; Xu L; Wang Z; Guo J; Xu J
Urol Oncol; 2022 Apr; 40(4):166.e15-166.e25. PubMed ID: 34998671
[TBL] [Abstract][Full Text] [Related]
33. Pyruvate dehydrogenase kinase expression and metabolic changes following dichloroacetate exposure in anoxic human colorectal cancer cells.
Ho N; Coomber BL
Exp Cell Res; 2015 Feb; 331(1):73-81. PubMed ID: 25536473
[TBL] [Abstract][Full Text] [Related]
34. Overexpression of placenta specific 8 is associated with malignant progression and poor prognosis of clear cell renal cell carcinoma.
Shi L; Xiao L; Heng B; Mo S; Chen W; Su Z
Int Urol Nephrol; 2017 Jul; 49(7):1165-1176. PubMed ID: 28349447
[TBL] [Abstract][Full Text] [Related]
35. Development of a polyamine gene expression score for predicting prognosis and treatment response in clear cell renal cell carcinoma.
Chen M; Nie Z; Huang D; Gao Y; Cao H; Zheng L; Zhang S
Front Immunol; 2022; 13():1048204. PubMed ID: 36505496
[TBL] [Abstract][Full Text] [Related]
36. Large-scale transcriptome profiles reveal robust 20-signatures metabolic prediction models and novel role of G6PC in clear cell renal cell carcinoma.
Xu WH; Xu Y; Tian X; Anwaier A; Liu WR; Wang J; Zhu WK; Cao DL; Wang HK; Shi GH; Qu YY; Zhang HL; Ye DW
J Cell Mol Med; 2020 Aug; 24(16):9012-9027. PubMed ID: 32567187
[TBL] [Abstract][Full Text] [Related]
37. FCER1G positively relates to macrophage infiltration in clear cell renal cell carcinoma and contributes to unfavorable prognosis by regulating tumor immunity.
Dong K; Chen W; Pan X; Wang H; Sun Y; Qian C; Chen W; Wang C; Yang F; Cui X
BMC Cancer; 2022 Feb; 22(1):140. PubMed ID: 35120484
[TBL] [Abstract][Full Text] [Related]
38. Selective modification of pyruvate dehydrogenase kinase isoform expression in rat pancreatic islets elicited by starvation and activation of peroxisome proliferator-activated receptor-alpha: implications for glucose-stimulated insulin secretion.
Sugden MC; Bulmer K; Augustine D; Holness MJ
Diabetes; 2001 Dec; 50(12):2729-36. PubMed ID: 11723055
[TBL] [Abstract][Full Text] [Related]
39. Golgi Alpha-Mannosidase II as a Novel Biomarker Predicts Prognosis in Clear Cell Renal Cell Carcinoma.
Li C; Guo L; Chen F; Yu W; Rao T; Ruan Y
Oncol Res Treat; 2020; 43(6):264-275. PubMed ID: 32403105
[TBL] [Abstract][Full Text] [Related]
40. Regulation of pyruvate dehydrogenase activity through phosphorylation at multiple sites.
Kolobova E; Tuganova A; Boulatnikov I; Popov KM
Biochem J; 2001 Aug; 358(Pt 1):69-77. PubMed ID: 11485553
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
